重大公告
The change of the Company’s business address was approved by the Board of Directors
1.Date of occurrence of the event:2023/11/06 2.Company name: OBI Pharma, Inc. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”): head office 4.Reciprocal shareholding …
Announcement of change of internal audit officer
1.Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.), financial officer, accounting officer, corporate governance officer, chief information …
Announcement of change of financial officer
1.Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.), financial officer, accounting officer, corporate governance officer, chief information …
Announcement of the Consolidated Financial Statements for the third quarter of 2023 were approved by the Board of Directors
1.Date of the board of directors submitted or approved:2023/11/06 2.Date of the audit committee approved:2023/11/03 3.Start and end dates of financial reports or unaudited financial …
Announcement on behalf of Amaran that the institutional director changes its representative
1.Date of occurrence of the change:2023/08/07 2.Name of legal person: OBI Pharma, Inc. 3.Name of the previous position holder: Michael Chang 4.Resume of the previous …